Insulin Therapy
Extraction, purification, dosing, monitoring, and later recombinant production of insulin for diabetes treatment.
Core metadata
- ID: insulin_therapy
- Era: Modern
- First known date: 1922 (exact)
- Region: Canada, United States, Europe, and global medicine
- Review status: source_checked
- Maturity: established
Prerequisites
Dependents
Fields
Field lanes
- Pharmaceuticals & Drug Development: Biologics & Vaccines
Node sources
- The Nobel Prize in Physiology or Medicine 1923 (Nobel Prize, 2026, museum) • Supports: node, maturity
- Recombinant DNA Technology (National Human Genome Research Institute, 2026, official_agency) • Supports: node, maturity
Prerequisite edge evidence
Edge/source evidence summary:
- Prerequisite edges: 2
- Average edge confidence: 68%
- Prerequisite sources: 2
- expert_inference: 2
| Prerequisite | Type | Confidence | Evidence level | Note | Sources |
|---|---|---|---|---|---|
| Biochemistry (biochemistry) | enabling | 68% | expert_inference | Biochemistry provides a capability that enables this technology without being the only possible path. |
|
| Laboratory Diagnostic Medicine (laboratory_diagnostic_medicine) | enabling | 68% | expert_inference | Laboratory Diagnostic Medicine provides a capability that enables this technology without being the only possible path. |
|
This page is generated from canonical era JSON and is indexable by URL.